Business & Industry
BioPharma
Chinese Pharmaceutical Firms Turn to Local Reagent Suppliers
The Chinese pharmaceutical firms are increasingly looking out for the local reagent suppliers so as to cut the costs as well as delivery times. Growing...
BioPharma
Medicine Manufacturers from Europe Eyeing US Tariff Move
The medicine manufacturers from Europe are bracing for President Donald Trump’s plan to slap tariffs of almost 250% on medicine imported from the EU.
The declaration...
BioPharma
America’s AI Action Plan Boosts Pharmaceutical Innovation
Accelerating Pharmaceutical and Biopharmaceutical Innovation through America’s AI Action Plan
America’s AI Action Plan, unveiled in July 2025, lays out a comprehensive strategy to propel the...
BioPharma
Trump To Roll-Out 340B Drugs Discount Program in 2026
The Trump administration is going to pilot a voluntary program in 2026, wherein the pharmaceutical companies can offer rebates for certain drugs to hospitals that...
BioPharma
60-Day Window by Trump for Firms to Lower Their Drug Prices
President Donald Trump of the USA has sent letters to the drug company CEOs demanding they lower their drug prices. The letters that have been...
BioPharma
Bavarian Nordic Agrees for a $3 Bn Take-Private Offer
Bavarian Nordic, the vaccine maker, on July 28 said that it has agreed in principle for roughly $3 bn take-private offer from private equity firms...
BioPharma
South Korea – A Biopharma Innovation Hub With 113% Growth
The biopharmaceutical sector of South Korea has seen a growth in innovators and drug licensing agreements by way of reaching a total deal value of...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.